John Paolini
Vermögen: 5 Mio $ am 31.07.2026
Vermögen: 5 Mio $ am 31.07.2026
John F.
Paolini is Chief Medical Officer & Senior Vice President at Kiniksa Pharmaceuticals Ltd. since 2016.
Dr. Paolini is Chief Medical Officer & Executive Vice President at Kiniksa Pharmaceuticals International Plc since 2024.
Former roles include Senior Director-Cardiovascular Disease at Merck & Co., Inc., Head-Clinical Research-Cardiovascular at Pfizer Inc. from 2015 to 2016, Member at the University of Pennsylvania, Clinical Associate at Pennsylvania Hospital, Principal at Bayer HealthCare Pharmaceuticals, Inc., and Chief Medical Officer at Cerenis Therapeutics, Inc. from 2011 to 2015.
Education includes undergraduate studies at Tulane University (Louisiana) and graduate and doctorate degrees from Duke University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,14 % | 01.05.2026 | 65.623 ( 0,14 % ) | 5 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01.08.2016 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Pennsylvania Hospital
Pennsylvania Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Corporate Officer/Principal | - |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pennsylvania Hospital
Pennsylvania Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen